Product Information
VUITY 1.25% EYE DROP is a brand product labeled by AbbVie Inc., priced at $23.3947 per ML under NDC 00074709806. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on Oct 28, 2021.
The High Outlier badge above means this manufacturer's average price in the Pilocarpine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/mL
Manufacturer
AbbVie Inc.NDC
00074709806
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA214028FDA Approved
10/28/2021
On Market Since
10/28/2021
Pharmacological Classes
Price Statistics
The NADAC for VUITY 1.25% EYE DROP has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.3947 per ML |
|---|---|
| All-time high | $23.5529 (May 13, 2026) |
| All-time low | $22.4228 (Sep 17, 2025) |
| 52-week high | $23.5529 |
| 52-week low | $22.4228 |
| Median price | $22.5763 |
| Average price | $22.7962 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VUITY 1.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for VUITY 1.25% EYE DROP, manufactured by AbbVie Inc., is $23.3947 per ML (NDC 00074709806), effective Aug 19, 2026.
How has the price of VUITY 1.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for VUITY 1.25% EYE DROP has risen 3.3%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for VUITY 1.25% EYE DROP?
Since Jun 19, 2024, the NADAC for VUITY 1.25% EYE DROP has ranged from a low of $22.4228 (Sep 17, 2025) to a high of $23.5529 (May 13, 2026), with a median of $22.5763 per ML.
Are there cheaper alternatives to VUITY 1.25% EYE DROP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VUITY 1.25% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures VUITY 1.25% EYE DROP?
VUITY 1.25% EYE DROP (NDC 00074709806) is labeled by AbbVie Inc., and CMS classifies it as a brand product.